No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation

[1]  G. Gerken,et al.  IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-p) , 1993, Annals of Hematology.

[2]  H. V. van Houwelingen,et al.  Towards functional transplant donor matching by measurement of granzyme A and granzyme B production levels. , 2004, Journal of immunological methods.

[3]  N. B. Lerner,et al.  Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials , 2003, Bone Marrow Transplantation.

[4]  W. Weimar,et al.  The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens , 2003, Transplantation.

[5]  K. Rezvani,et al.  New developments in allotransplant immunology. , 2003, Hematology. American Society of Hematology. Education Program.

[6]  G. Healey,et al.  The helper T lymphocyte precursor (HTLp) frequency does not predict outcome after HLA-identical sibling donor G-CSF-mobilised peripheral blood stem cell transplantation , 2002, Bone Marrow Transplantation.

[7]  B. Meister,et al.  In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation. , 2002, Journal of hematotherapy & stem cell research.

[8]  D. Paniagua,et al.  Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C. Heilmann,et al.  The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation , 2001, Bone Marrow Transplantation.

[10]  A. Leung,et al.  Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings. , 2001, Haematologica.

[11]  X. N. Wang,et al.  T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation. , 2000, Transplantation.

[12]  C. Perreault,et al.  Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor , 2000, Bone Marrow Transplantation.

[13]  S. Singhal,et al.  Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation , 2000, Bone Marrow Transplantation.

[14]  杉森 尚美.  Administration of G-CSF to normal individuals diminishes L-selectin[+] T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin[-] T cells , 1999 .

[15]  S. Nakao,et al.  Administration of G-CSF to normal individuals diminishes L-selectin+ T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin− T cells , 1999, Bone Marrow Transplantation.

[16]  I. Joosten,et al.  Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT , 1998, Bone Marrow Transplantation.

[17]  F. Re,et al.  Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells , 1998, Bone Marrow Transplantation.

[18]  G. Benichou,et al.  The presentation of self and allogeneic MHC peptides to T lymphocytes. , 1998, Human immunology.

[19]  P. Bierling,et al.  Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies. , 1997, Transplantation.

[20]  L. Weston,et al.  Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. , 1997, Transplantation.

[21]  N. Flomenberg,et al.  Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation , 1997, Bone Marrow Transplantation.

[22]  D. S. Sivia,et al.  Data Analysis , 1996, Encyclopedia of Evolutionary Psychological Science.

[23]  A. Gratwohl,et al.  Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. , 1995, Blood.

[24]  J. Goldman,et al.  CYTOTOXIC T LYMPHOCYTE PRECURSOR FREQUENCY ANALYSES IN BONE MARROW TRANSPLANTATION WITH VOLUNTEER UNRELATED DONORS VALUE IN DONOR SELECTION , 1995, Transplantation.

[25]  H. Heimpel,et al.  Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease. , 1995, Bone marrow transplantation.

[26]  M. Cooley,et al.  Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation. , 1994, Transplantation.

[27]  H. Heimpel,et al.  Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells. , 1993, Bone marrow transplantation.

[28]  H. Bontkes,et al.  High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD. , 1993, Bone marrow transplantation.

[29]  R. Lechler,et al.  Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation , 1993, The Lancet.

[30]  H. Heimpel,et al.  Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. , 1992, The New England journal of medicine.

[31]  A. Barrett,et al.  Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells. , 1991, Bone marrow transplantation.

[32]  S. Mackinnon,et al.  Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. , 1989, Transplantation.

[33]  E. Goulmy.  Minor Histocompatibility antigens in man and their role in transplantation. , 1988 .

[34]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[35]  C. Taswell,et al.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.

[36]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.

[37]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.